Company / R&D per Share
Amneal Pharmaceuticals, Inc. R&D per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.06
FY2025
5-year range
$1.06 / $1.42
FY2021-FY2025
Trend
-16.3%
vs FY2024
Sector context
#144 of 208
Health Care
What the data says
At $1.06, Amneal Pharmaceuticals, Inc.'s r&d per share ranks #144 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 9 years, ranging from $1.06 in FY2025 to $171420.00 in FY2017.
Based on SEC 10-K filings.
1.06 in FY2025 with a 5-year CAGR of -7.1%.
Declined from $1.33 to $1.06 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.0%
- 5-Year CAGR
- -7.1%
- 10-Year CAGR
- -
Sector benchmark
#144 of 208 in Health CareTop 69% of 208This company $1.06 Sector average $28.82
▼
-96.3% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 16.3% year-over-year.
- Ranks #144 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.06 | -16.3% |
| FY2024 | $1.26 | -5.0% |
| FY2023 | $1.33 | +1.2% |
| FY2022 | $1.31 | -7.7% |
| FY2021 | $1.42 | -6.7% |
| FY2020 | $1.53 | +13.3% |
| FY2019 | $1.35 | -4.2% |
| FY2018 | $1.41 | -100.0% |
| FY2017 | $171420.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026